Saraci Marsida 4
Research Summary
AI-generated summary
Alphabet (GOOGL) VP Saraci Marsida Sells 449 Shares
What Happened
Saraci Marsida, Vice President and Chief Accounting Officer of Alphabet, reported conversion of multiple Google Stock Units (GSUs) on June 25, 2026. A portion of the vested shares were withheld to satisfy tax obligations, and 449 Class C shares were sold in the open market on June 26, 2026 for a weighted average price of $341.72, yielding about $153,432. The sale was executed under a pre-established Rule 10b5‑1 trading plan.
Key Details
- Transaction types: multiple GSU conversions (derivative code C) on 2026-06-25; shares withheld to pay taxes (code F); open-market sale (code S) on 2026-06-26.
- Open-market sale: 449 shares at a weighted average price $341.72, total proceeds ≈ $153,432. Reported sale prices ranged $341.72–$342.72.
- Tax withholding: multiple F entries show shares withheld to satisfy taxes (total ~453 shares withheld, representing roughly $156k at ~$345.04 per share as reported for withholding).
- Footnotes: GSUs convert to one Class C share per unit as they vest (various vesting schedules noted). Footnote F3 specifically denotes shares withheld to satisfy tax obligations.
- 10b5‑1 plan: Sale reported as executed pursuant to a Rule 10b5‑1 plan adopted May 19, 2025.
- Filing/timeliness: Form 4 filed 2026-06-29 covering transactions dated 2026-06-25 and 06-26; filing appears timely based on reported dates.
- Shares owned after transaction: not stated in the excerpt provided.
Context
- These were vesting/conversion events of restricted GSUs, not open-market purchases; tax withholding using shares is common when RSUs/GSUs vest.
- The 10b5‑1 plan indicates the open-market sale was preplanned; such pre-established plans are used to avoid allegations of trading on inside information.
- For retail investors: purchases are generally more informative as bullish signals; this filing mainly documents routine vesting, tax-withholding, and a planned sale rather than a discretionary market-timed trade.